VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer

NCT03690986 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

BIOLOGICAL: VX15/2503
BIOLOGICAL: Ipilimumab
BIOLOGICAL: Nivolumab

Sponsor

Emory University

Collaborators

[object Object]